EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased serum fibroblast growth factor 2 levels, altered peripheral blood inflammatory indicators and their ratios in amyotrophic lateral sclerosis: a clinical exploratory study

Xiaoting Niu, Meijuan Zhang, Huanjie Huang, Bei Shao, Xun Wang, Zhengyi Cai

Frontiers in Neurology · 18.08.2026 · 17

DOI: 10.3389/fneur.2026.1859903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Neurology, online erschienen am 18.08.2026. Verfasst von Xiaoting Niu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Fibroblast Growth Factor 2, Inflammation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by motor neuron degeneration, leading to muscle weakness, atrophy, and ultimately respiratory failure. Previous research has highlighted the roles of neurotrophic factors and inflammatory responses in ALS pathogenesis; however, their interplay remains poorly understood. This exploratory study aims to elucidate the expression characteristics and correlations of fibroblast growth factor 2 (FGF2) and peripheral blood inflammatory indicators (PBIIs) such as derived neutrophil-to-lymphocyte ratio (dNLR) and systemic inflammatory response index (SIRI) in ALS patients.

Methods

This was a prospective case–control study, involving ALS patients meeting Gold Coast diagnostic criteria and age- and sex-matched healthy controls (HCs). Serum FGF2 levels were measured using enzyme-linked immunosorbent assay (ELISA), and PBIIs were assessed through routine blood analysis. Statistical analysis was conducted mainly using intergroup comparison, correlation analysis, and multivariate linear regression.

Results

The results showed significantly elevated levels of FGF2 and PBIIs in ALS patients compared to HCs, with strong correlations between FGF2, PBIIs, clinical staging, and disease progression rates. In multivariate linear regression analysis, PBIIs, especially SIRI, were significantly associated with disease severity and early disease progression. While serum FGF2 and FGF2 to dNLR ratio demonstrated potential as an auxiliary biomarker for later-stage disease.

Discussion

These findings provide new insights into the molecular mechanisms underlying ALS and suggest practical diagnostic and prognostic tools, reinforcing the importance of targeting neurotrophic and inflammatory pathways in ALS management. This study holds significant promise for advancing both clinical practice and future research endeavors in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisFibroblast Growth Factor 2InflammationHumansFemaleMaleCase-Control StudiesMiddle AgedBiomarkersProspective StudiesAgedAdultDisease ProgressionNeutrophils

Stichwörter der Autor:innen

amyotrophic lateral sclerosisclinical exploratory studyfibroblast growth factor 2peripheral blood inflammatory indicatorsratio

Substanzen

Fibroblast Growth Factor 2Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Zitieren

APA

Niu, X., Zhang, M., Huang, H., Shao, B., Wang, X., & Cai, Z. (2026). Increased serum fibroblast growth factor 2 levels, altered peripheral blood inflammatory indicators and their ratios in amyotrophic lateral sclerosis: a clinical exploratory study. Frontiers in Neurology, 17. https://doi.org/10.3389/fneur.2026.1859903

Vancouver

Niu X, Zhang M, Huang H, Shao B, Wang X, Cai Z. Increased serum fibroblast growth factor 2 levels, altered peripheral blood inflammatory indicators and their ratios in amyotrophic lateral sclerosis: a clinical exploratory study. Frontiers in Neurology. 2026;17. doi:10.3389/fneur.2026.1859903

BibTeX
@article{Niu2026,
  author = {Niu, Xiaoting and Zhang, Meijuan and Huang, Huanjie and Shao, Bei and Wang, Xun and Cai, Zhengyi},
  title = {Increased serum fibroblast growth factor 2 levels, altered peripheral blood inflammatory indicators and their ratios in amyotrophic lateral sclerosis: a clinical exploratory study},
  journal = {Frontiers in Neurology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fneur.2026.1859903}
}
Kostenlos starten →